UBS Remains Sidelined on Exelon Corp. (EXC) Despite Positive Investor Sentiment
Get Alerts EXC Hot Sheet
Rating Summary:
9 Buy, 18 Hold, 2 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
UBS maintained a Neutral rating on Exelon (NYSE: EXC), and cut the price target to $30.00 (from $33.00), despite bullish sentiment from investors. UBS sees the close of the POM deal as critical to sentiment. Should it close, UBS sees a clear upside to valuation from simple accretion, as well as ROE upside should management prove capable in turning around operations.
Analyst Julien Smith commented, "Despite continued bullish sentiment from investors to the contrary, we remain on the sidelines despite the ~16% underperformance vs. the XLU in 2015. While admittedly the IPP sector valuations are at decade lows, we see arguments around ‘Utility + Parent’ ignoring the fact that ExGen is not necessarily cheap compared with IPP comps."
For an analyst ratings summary and ratings history on Exelon click here. For more ratings news on Exelon click here.
Shares of Exelon closed at $27.94 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Upgrades United Microelectronics Corp (2303:TT) (UMC) to Buy 'with limited downside'
- Equity Residential (EQR) PT Raised to $70 at Evercore ISI
- Equifax (EFX) PT Lowered to $263 at Citi
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!